30
Participants
Start Date
January 31, 2025
Primary Completion Date
January 31, 2026
Study Completion Date
February 28, 2026
Hemofiltration membranes (the oXiris membrane® and the HF1400® membrane)
The PRISMAFLEX® or PRISMAX® control unit (pre- and post-dilution with a prescribed treatment dose \> 25 ml/kg/h) with regional citrate anticoagulation and a substitution solution by PHOXILLUM will be used regardless of the type of membrane used (the oXiris membrane and the HF 1400 membrane), also as part of routine care provided in the ICU.
RECRUITING
Hopital Haut-Lévêque, Pessac
Baxter Healthcare Corporation
INDUSTRY
University Hospital, Bordeaux
OTHER